Conference Proceedings

RNA molecular signatures as predictive biomarkers of response to monotherapy pembrolizumab in patients with metastatic triple-negative breast cancer: KEYNOTE-086

Sherene Loi, Peter Schmid, Javier Cortes, David W Cescon, Eric P Winer, Deborah Toppmeyer, Hope S Rugo, Michelino De Laurentiis, Rita Nanda, Hiroji Iwata, Ahmad Awada, Antoinette Tan, Chunsheng Zhang, Andrey Loboda, Andrew Albright, Razvan Cristescu, Maureen Lane, Anran Wang, Jared Lunceford, Gursel Aktan Show all

Clinical Research (Excluding Clinical Trials) | AMER ASSOC CANCER RESEARCH | Published : 2019